Literature DB >> 17694434

Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Trevor Archer1, Anders Fredriksson.   

Abstract

The influence of postnatal iron overload upon implications of the functional and interactive role of dopaminergic and noradrenergic pathways that contribute to the expressions of movement disorder and psychotic behaviours in mice was studied in a series of experiments. (1) Postnatal iron overload at doses of 7.5 mg/kg (administered on Days 10-12 post partum) and above, invariably induced a behavioural syndrome consisting of an initial (1st 20-40 min of a 60-min test session) hypoactivity followed by a later (final 20 min of a 60-min test session) hyperactivity, when the mice were tested at adult ages (age 60 days or more). (2) Following postnatal iron overload, subchronic treatment with the neuroleptic compounds, clozapine and haloperidol, dose-dependently reversed the initial hypoactivity and later hyperactivity induced by the metal. Furthermore, DA D(2) receptor supersensitivity (as assessed using the apomorphine-induced behaviour test) was directly and positively correlated with iron concentrations in the basal ganglia. (3) Brain noradrenaline (NA) denervation, using the selective NA neurotoxin, DSP4, prior to administration of the selective DA neurotoxin, MPTP, exacerbated both the functional (hypokinesia) and neurochemical (DA depletion) effects of the latter neurotoxin. Treatment with L-Dopa restored motor activity only in the animals that had not undergone NA denervation. These findings suggest an essential neonatal iron overload, termed "the Youdim factor", directing a DA-NA interactive component in co-morbid disorders of nigrostriatal-limbic brain regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694434     DOI: 10.1007/s11064-007-9358-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  96 in total

1.  Brain iron: a lesson from animal models.

Authors:  S Yehuda; M B Youdim
Journal:  Am J Clin Nutr       Date:  1989-09       Impact factor: 7.045

2.  Increased nigral iron content in postmortem parkinsonian brain.

Authors:  D T Dexter; F R Wells; F Agid; Y Agid; A J Lees; P Jenner; C D Marsden
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

3.  Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.

Authors:  D Ben-Shachar; B Pinhassi; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-09-17       Impact factor: 4.432

4.  Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.

Authors:  M Marien; M Briley; F Colpaert
Journal:  Eur J Pharmacol       Date:  1993-06-04       Impact factor: 4.432

Review 5.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

6.  Iron-dependent enzymes in Parkinson's disease.

Authors:  H Reichmann; B Janetzky; P Riederer
Journal:  J Neural Transm Suppl       Date:  1995

7.  Serotonin and fear retention in the rat.

Authors:  T Archer
Journal:  J Comp Physiol Psychol       Date:  1982-06

8.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

Review 9.  Iron modulates neuroleptic-induced effects related to the dopaminergic system.

Authors:  D Ben-Shachar; E Livne; I Spanier; R Zuk; M B Youdim
Journal:  Isr J Med Sci       Date:  1993-09

10.  DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

Authors:  G Jonsson; H Hallman; F Ponzio; S Ross
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more
  6 in total

1.  Physical exercise attenuates MPTP-induced deficits in mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2010-03-19       Impact factor: 3.911

2.  Effect of olfactory manganese exposure on anxiety-related behavior in a mouse model of iron overload hemochromatosis.

Authors:  Qi Ye; Jonghan Kim
Journal:  Environ Toxicol Pharmacol       Date:  2015-06-23       Impact factor: 4.860

3.  Running wheel activity restores MPTP-induced functional deficits.

Authors:  Anders Fredriksson; Ingels Maria Stigsdotter; Anders Hurtig; Béatrice Ewalds-Kvist; Trevor Archer
Journal:  J Neural Transm (Vienna)       Date:  2010-09-18       Impact factor: 3.575

4.  Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia.

Authors:  Argel Aguilar-Valles; Cecilia Flores; Giamal N Luheshi
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

Review 5.  Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: a systematic review.

Authors:  Sonal Agrawal; Kiersten L Berggren; Eileen Marks; Jonathan H Fox
Journal:  Nutr Rev       Date:  2017-06-01       Impact factor: 7.110

6.  Brain iron loading impairs DNA methylation and alters GABAergic function in mice.

Authors:  Qi Ye; Malav Trivedi; Yiting Zhang; Mark Böhlke; Helal Alsulimani; JuOae Chang; Timothy Maher; Richard Deth; Jonghan Kim
Journal:  FASEB J       Date:  2018-10-02       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.